Evidence map›Paper›PMID 39055669›Full record

ArticleSAGE open medical case reports2024

Glycemic impact of gabapentin and Nucleo C.M.P in metformin-controlled diabetic patients: A case report.

Hashim Talib Hashim, Ahmed Qasim Mohammed Alhatemi, Narjiss Aji, Jaffer Shah

Abstract readCase Reports
In one paragraph

Article in SAGE open medical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hashim Talib HashimCollege of Medicine, Warith Al Anbiyaa University, Karbala, Iraq.
Ahmed Qasim Mohammed AlhatemiDepartment of Internal Medicine, Al Nasiriyah Teaching Hospital, Thi Qar, Iraq.ORCID https://orcid.org/0009-0004-9076-8220
Narjiss AjiCollege of Medicine, University of Drexel, Philadelphia, PA, USA.
Jaffer ShahFaculty of Medicine and Pharmacy of Rabat, Mohammed V University of Rabat, Rabat, Rabat-Sale-Kenitra, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study examines the contraindications of gabapentin and Nucleo C.M.P Forte in metformin-controlled diabetic patients, focusing on their potential to induce hyperglycemia. A case report of a 65-year-old woman with type II diabetes is presented, demonstrating elevated blood glucose levels following the initiation of gabapentin and Nucleo C.M.P Forte. The literature review highlights limited data on gabapentin-induced hyperglycemia, with additional consideration of the potential effects of Nucleo C.M.P Forte. The study suggests modifying insulin therapy in diabetic patients taking gabapentin and calls for further research on this interaction.

Indexed as

diabetes mellitusdiabetic neuropathygabapentinintervertebral disk displacementMetformin

Identifiers

PMID39055669
PMCPMC11271094

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.